Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Synthesis and Characterization of Biodegradable Poly(ether-Ester) Urethane Acrylates for Controlled Drug Release.

Design and synthesis of poly(butyl acrylate) networks through RAFT polymerization with crosslinking for controlled-release applications

Novel cationic poly(ester-co-carbonate) materials functionalized with tertiary amine groups

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Synthesis, characterization and in vitro degradation of a new family of alternate poly(ester-anhydrides) based on aliphatic and aromatic diacids

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Preparation, Characterization and Degradation Characteristics of Polyanhydrides Containing Poly(Ethylene Glycol)

Preparation and rapid degradation of nontoxic biodegradable polyurethanes based on poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) and l -lysine diisocyanate

Controlled release of dexamethasone acetate from biodegradable and biocompatible polyurethane and polyurethane nanocomposite

Biomedical Segmented Polyurethanes Based on Polyethylene Glycol, Poly(ε-Caprolactone-co-d,l-lactide), and Diurethane Diisocyanates with Uniform Hard Segment: Synthesis and Properties

Synthesis and Drug Controlled Release of Block Copolymers of Poly(l‐lactide) with Poly(d, L‐lactide) and Related Monomers

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

Synthesis, Characterization and in Vitro Degradation of A Novel Degradable Poly((1,2-Propanediol-Sebacate)-Citrate) Bioelastomer

Synthesis, Characterization and Biocompatibility of Biodegradable Elastomeric Poly(ether-ester Urethane)s Based on Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) and Poly(ethylene Glycol) Via Melting Polymerization

Synthesis and Characterization of Biodegradable Polyurethanes with Unsaturated Carbon Bonds Based on Poly(Propylene Fumarate)

Synthesis and characterization of phosphoryl-choline-capped poly(ε-caprolactone)-poly(ethylene oxide) di-block co-polymers and its surface modification on polyurethanes

Performance Study of Biodegradable Polyurethanes from Different Biodicarboxylic Acids and Their Potential Applications

Synthesis and properties of novel degradable polyglycolide-based polyurethanes

Synthesis and properties of biodegradable poly(ester-urethane)s based on poly(ε-caprolactone) and aliphatic diurethane diisocyanate for long-term implant application: effect of uniform-size hard segment content

Synthesis and Characterizations of Biodegradable Polyurethane Microspheres with Dexamethasone for Drug Delivery

Development of lactic acid based chain extender and soybean oil-derived polyurethanes for ecofriendly sustained drug delivery systems